PDCD1 and lymphoma: Active RA treatment at lymphoma diagnosis was associated with higher numbers of PD-1+ TILs in the RA-DLBCL group, but no difference was seen regarding PD-1+ TILs between the groups treated with either DMARDs or corticosteroids in monotherapy or both in combination.